Trisomy X News and Research

RSS
Non-invasive prenatal testing for Down's syndrome acceptable to parents

Non-invasive prenatal testing for Down's syndrome acceptable to parents

Non-invasive prenatal testing can detect maternal cancer at early stage

Non-invasive prenatal testing can detect maternal cancer at early stage

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Findings of Ariosa's non-invasive prenatal testing study published online in NEJM

Researchers analyze false-positive results from new prenatal genetic screens

Researchers analyze false-positive results from new prenatal genetic screens

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

BGI study tracks accuracy of NIFTY prenatal test

BGI study tracks accuracy of NIFTY prenatal test

Cell-free fetal DNA testing more effective in detecting Down syndrome

Cell-free fetal DNA testing more effective in detecting Down syndrome

BGI Diagnostics develops ‘education hub’ to raise awareness about non-invasive prenatal testing

BGI Diagnostics develops ‘education hub’ to raise awareness about non-invasive prenatal testing

Epizyme presents EPZ-5676 Phase 1 trial results for acute leukemia at ASH 2014

Epizyme presents EPZ-5676 Phase 1 trial results for acute leukemia at ASH 2014

Decision-support guide for prenatal genetic testing, no cost for testing result in less prenatal test use

Decision-support guide for prenatal genetic testing, no cost for testing result in less prenatal test use

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Computational biologists develop program for easy diagnosis of hereditary illnesses

Computational biologists develop program for easy diagnosis of hereditary illnesses

NIFTY test becomes first CFDA approved NIPT based on Next Generation Sequencing Technology

NIFTY test becomes first CFDA approved NIPT based on Next Generation Sequencing Technology

Sequenom signs national agreement to provide MaterniT21 PLUS LDT

Sequenom signs national agreement to provide MaterniT21 PLUS LDT

Study sheds light on how extra chromosome 21 upsets equilibrium of entire genome in Down syndrome

Study sheds light on how extra chromosome 21 upsets equilibrium of entire genome in Down syndrome

cfDNA testing lowers false positive rates and higher predictive values in general obstetric population

cfDNA testing lowers false positive rates and higher predictive values in general obstetric population

Natera initiates distribution partnership with ProPath for Panorama non-invasive prenatal screening test

Natera initiates distribution partnership with ProPath for Panorama non-invasive prenatal screening test

Study: Noninvasive prenatal testing detects 83.2% of chromosomal abnormalities

Study: Noninvasive prenatal testing detects 83.2% of chromosomal abnormalities

BGI Health to introduce NIFTY screening test to reduce miscarriages

BGI Health to introduce NIFTY screening test to reduce miscarriages